International Beneficence Clinical Research L L C entered the industry of Medical Labs in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.
To acquire more information, please contact Jose Martin Hernandez by calling (956) 423-0045 during business hours. You can also write to the business’ Single Location at 913 East Harrison Avenue # 5, Harlingen, Texas TX 78550. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | International Beneficence Clinical Research L L C |
Representative: | Jose Martin Hernandez |
Place of Business: | 913 East Harrison Avenue # 5, Harlingen, TX 78550 |
Contact Number: | (956) 423-0045 |
Type of Service: | Medical Labs |
SIC Number: | 8071 |
NAICS Number: | 621511 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
International Beneficence Clinical Research L L C is a company operating from Cameron, Texas providing professional Medical Labs and relevant B2C variables. It was founded in 0 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 621511 as Medical Labs.
With a current employee count of 1 to 4, International Beneficence Clinical Research L L C has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Jose Martin Hernandez at (956) 423-0045 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 913 East Harrison Avenue # 5 in Harlingen, Texas 78550 and can be engaged online through the company website at , the company Twitter , and Facebook page .